Current GMP Guidelines

Similar documents
Cleaning and Contamination Control

DISCUSSION TOOL PRESENTED TO THE AABB CT REGULATORY AFFAIRS SUBSECTION

INTRODUCING THE NEW. Xcelodose S. New Powder Micro-dosing System. Even Faster Time to First in Man

Microbiology and Auditing. Don Singer

Good Manufacturing Practices for the Production of Packaging Inks formulated for use on the non food contact surfaces of food packaging and articles

Comparison between FDA QSR and ISO 13485

GEA Niro Pharmaceutical GMP Spray Drying facility. Spray drying process development and contract manufacturing. engineering for a better world

MEDICINES CONTROL COUNCIL

Pharmaceutical Quality Systems: US Perspective

Are you protected? PharmaShield. The Evolution of Generics

FDA Inspection Observations The FDA 483 and Beyond. Objectives

Combination Products. Presented by: Karen S. Ginsbury For: IFF March PCI Pharma

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

FILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS

Particle Monitoring Requirements in Pharmaceutical Cleanrooms

FDA and the Compounding Pharmacy

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

Cleanroom. For. Sterile Manufacturing Facilities

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

MeriCal Quality Profile

GEA Niro Pharmaceutical Spray Drying

Customized Nutritional Solutions For Laboratory Animals

Extemporaneously Prepared Early Phase Clinical Trial Materials

UNICEF s Quality Assurance System for procurement of medicines

Library Guide: Pharmaceutical GMPs

Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.

Corden Pharma Latina S.p.A. 5/20/16

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

Chapter 5 Water, Plumbing, and Waste

Overcoming Challenges in the Manufacturing of Pre-Filled Syringes. Farvea, a new comer in the PFS world PFS Tech June 2016 pharma@fareva.

Cleaning Validation in Active pharmaceutical Ingredient manufacturing plants

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

Pharmaceutical waste disposal Guideline. Guideline for Disposal of Pharmaceutical waste (1 st Edition, 2014)

HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR

How To Control A Medical Device With A Pc System

Sandoz Private Limited 10/22/15

EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4


21 Code of Federal Regulations Parts 210 and 211

Monitoring manufacturing, production and storage environments in the pharmaceutical industry

Liquids Suspensions Gels

"ADOPTED STANDARDS FOR THE REGULATION OF MEDICAL WASTE" IN HEALTH CARE FACILITIES LICENSED BY THE MISSISSIPPI STATE DEPARTMENT OF HEALTH

How to Prepare Powdered Infant Formula in Care Settings

Guidance for Industry

Journal of Chemical and Pharmaceutical Research

Cosmetics for your own brand 100% Made in France

Annex 7 Guidelines on pre-approval inspections

FOREWORD. The Plastics Pipe Institute. This Technical Note, TN-30, was first issued in January 2006 and was revised and republished in September 2013.

BSL3 and BSL4 Autoclaves. Laboratory Line

Guide to Master Formulae WHO/FWC/IVB/QSS/VQR

Environmental Chamber. Stability/ GMP 2000 Series. Stability Testing Chambers

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN

National Food Safety standard of the People s Republic of China

The FDA recently announced a significant

CH204 Experiment 2. Experiment 1 Post-Game Show. Experiment 1 Post-Game Show continued... Dr. Brian Anderson Fall 2008

Astellas Ireland Company Ltd. (Kerry Plant) Ampoule Inspection Machine. Eoin O Sullivan 5th June 2014

Environmental Monitoring of Clean Rooms

Introduction to Enteris BioPharma

BIO MEDICAL WASTE MANAGEMENT

Kompressoren. Oil Water Separators OWS

Safe Dry Goods Storage

Determining the Quantity of Iron in a Vitamin Tablet. Evaluation copy

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

cgmp Challenges for Cord Blood Banks

Quality Systems Appropriate for Extemporaneously Prepared Early Phase Clinical Trial Materials. Agenda Topics for Discussion

Sterile operation scenarios at GSK-Parma

Leila Kakko Tampere University of Applied science TRADITIONAL FOOD IN COMBATING FOODBORNE PATHOGENS 2011

Washing. Sterilising. Filling. Closing. Inspecting. Labelling

UNICEF s Quality Assurance System for Procurement of Micronutrient Powders (MNP)

THE PHARMACEUTICAL INDUSTRY

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *

Compilation of key GMP requirements in us and Japan for Tablet Manufacturing

2014 Annual Report on Inspections of Establishments

World Health Organization Prequalification of Medicines

GMP ANNEX 1 REVISION 2008, INTERPRETATION OF MOST IMPORTANT CHANGES FOR THE MANUFACTURE OF STERILE MEDICINAL PRODUCTS

On-Site GMP Training GMP COMPLIANCE TECHNICAL

durable performance horizontal basket Centrifuges

Guidance for Industry: Starting Material Supplier Management

TABLE OF CONTENTS CHAPTER 14 TELEPHARMACY RULES AND REGULATIONS

Documents, Records and Change Control

PROCESS VALIDATION OF TABLETS: AN OVERVIEW

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

POWDER PROPERTIES LABORATORY

BEST PRACTICE FOR MAXIMUM TABLET QUALITY, AVOIDING THE FDA WARNING LETTER 483.

Using the Surface Zeta Potential Cell Kit

How To Understand The Pharmacology Of The Pharmaceutical Industry

INTRODUCTION TO MACHINE-VISION INSPECTION

MEDICAL WASTE DISPOSAL POLICY. EFFECTIVE DATE: January 31, 1991 REVISED DATE: April 1, 2008 I. AUTHORITY TO ESTABLISH DISPOSAL POLICY:

Planning Engineering Projects management of Pharmaceutical Plants

Production/Machine Operator Life Sciences CURRICULUM/SYLLABUS

Biosafety Program University of Colorado. BSL-1 Audit Checklist

Welcome to the ChemCon Company Presentation: 6 Steps to Success for our Customers!

Treatment Centers for Radioactive Waste

100 Series Maxi Internal Filters. Instruction Manual

Regulatory Expectations for GMP: What s Happening. Patricia Weideman, PhD Director, Product Quality & Occupational Toxicology Genentech, Inc.

Timeworks Manufacturing Services

Electric Kettle. Model: SK-1717 INSTRUCTIONS MANUAL

High Performance Dry Binding with CELNY-SSL Super Fine Powder

Transcription:

Introduction is a system for ensuring that products are consistently produced and controlled according to the quality standards. It is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. 2 It is designed to ensure that mistakes do not occur again.

Introduction The quality cannot be tested into a batch of products but must be built into each batch of product during all stages of the manufacturing process. There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process. 3

Introduction 4

Introduction Metal contamination Wire inside the tablet 5 From source Raw material API / excipient From the sifter From compression M/C cgmp

Introduction 100% security sifting Passing through 30 mesh for fine powder 100 mesh Magnetic grills at the sifter outlet. 6

Introduction Metallic contamination during compression practice Metal detector in compression machine chute Any metallic piece of 0.1 mm size is detected tablet discarded 7

Introduction Metal detector can be installed in Tablet compression M/C Capsule filling M/C Dry syrup filling M/C Liquid oral filling After filling, Vial filling before capping 8

Introduction Roller Compactor Sifter Regular check up for surface intactness Pre and post checks 9

Introduction are the practices required to confirm the guidelines recommended by agencies that control and for manufacture and sale of food, drug products and active pharmaceutical products. 10 These guidelines provide minimum requirements that a pharmaceutical or food product manufactures must meet to assure that the products are of high quality and do not pose any risk to the consumer or public.

Introduction 11 is a common term. is a unique term to define most recent guidelines with improvement and additions.

Introduction regulations given by the under the authority of Federal Food, Drug and Cosmetic Act. As per the current good manufacturing practice process validation (updated) 1976 onwards :- called 12 GMP cgmp

Introduction of the regulations pertaining to food and drugs. contains most 13 Part 210 Part 211 Current good manufacturing practices in manufacturing process is packing and holding of drug. Current for finished pharmaceuticals.

Introduction By saying that any company employs it indicates that they are following 210 and 211 and no other. The office of compliance division of manufacturing and product quality web page provides link to in-process change in regulations announced in federal register. 14

Introduction The FDA regulations are printed in (21 CFR). In addition, the FDA and other government agencies publish new regulations and proposals in the federal register throughout the year. 15 Books on 21 CFR can be purchased from US government printing office.

Introduction Title 21, code of federal regulation (21 CFR) is updated on April 1 st of each year. The current edition contains nine volumes and is printed in paper back books. 16

Introduction Current good manufacturing practices for finished pharmaceuticals. Subpart A General Provision Subpart B Organization and Personnel Subpart C Buildings and Facilities 17 Subpart D Equipment

Introduction Current good manufacturing practices for finished pharmaceuticals. Subpart E Control of components and drug product containers and closures Subpart F Production and process controls Subpart G Packaging and Labelling Control 18 Subpart H Holding and Distribution

Introduction Current good manufacturing practices for finished pharmaceuticals. Subpart I Laboratory Control Subpart J Records and reports Subpart K Returned and Salvaged Drug Products 19

Introduction 20

Introduction 21

Introduction 22

Sec. 211.42 - Design and Construction features 23

Subpart C Building and facilities Beta lactam antibiotics such as penicillin, cephalosporin and penems : separate manufacturing areas Separate or defined areas for the manufacture and processing of non penicillin beta lactam products to prevent contamination 24

Subpart C Building and facilities At the time of designing and construction of the premises: Preferably separate blocks for penicillin and non penicillin products. Each block should be like a one factory. No movement of workers from one block to another block. 25

Sec. 211.46 - Ventilation, air filtration, air heating and cooling. 26

Subpart C Building and facilities Previously corridors were not defined areas Air bleeding from corridors 27 Process corridors Clean air Class 1,00,000 - minimum requirement Positive pressure

Subpart C Building and facilities Air locks Bubble locks Pressurized with respect to adjacent area Process area and adjacent area classified 28 Ventilation Oral formulation area 10 air change Parenterals formulation area 20 air change

Sec. 211.50 - Sewage and refuse 29

Subpart C Building and Facilities Air outlet in the environment Air should be passed through 0.22 µm double HEPA filter 30 For preventing contamination For the healthy environment

Subpart C Building and Facilities For decontamination of penicillin and cephalosporin Treatment with 2% NaOH solution 31

Subpart C Building and Facilities In other cases Drug powder converted into slurry Incinerator Converted to Ash 32 Ashes buried in the pits

Sec. 211.67 - Equipment cleaning and maintenance 33

Subpart D Equipment Clean Down Validation Cleaning procedure Validated Pressurized hot water guns are used 50-60 C hot water The testing is done on worst molecule i.e - Having low aqueous solubility - Very potent drug 34

Subpart D Equipment 35 Clean Down Validation Standardization is done with respect to : Volume of water Time Machine Surface area of contact Pressure of water Temperature

Subpart D Equipment Process is validated No need to wait for the result of residue of drug in the rinse water 36 (Limit of 5 PPM)

Sec. 211.130 - Packaging and labeling operations 37

Subpart G Packaging and labelling control Accountability of all packaging materials. Systems to ensure printed labels are not mixed. Electronic readers are employed Pharma codes on all printed materials Auto reading Auto rejection Roll labels are used less chance of mix ups 38

Sec. 211.176 - Penicillin contamination 39

Subpart I Laboratory control Penicillin / Semi synthetic Penicillin Testing of non penicillin products for traces of penicillin or cephalosporin contamination 40 Sophisticated test methodology required

Subpart I Laboratory control Penicillin / Semi synthetic Penicillin Air sample test should be reported in volume of air 41 Surface testing Should be capable of reflecting true value of contamination Valid swab sampling technique required

Sec. 211.180 General requirement 42

Subpart J Records and Reports Automatic machine/ equipments Computerized Results are recorded Maintaining data online Online Documentation 43

Subpart J Records and Reports Environmental control : Temperature Pressure differential RH Automatically recorded Data integrity maintained 44

Subpart J Records and Reports Data Integrity Data integrity refers to maintaining and assuring the accuracy and consistency of data over the entire data cycle. 45

Subpart J Records and Reports Data Integrity Governance system should ensure data integrity and traceability. System should be designed in a way which encourages compliance with the principle of contemporary record keeping. 46

Subpart J Records and Reports Data Integrity Example Access to clocks for recording timed events Accessibility of batch records at locations where activities take place 47 Automated data capture or printers attached to equipment

Thank you 48

49